The Dissemination of Consensus Recommendations on Upper Gastrointestinal Bleeding

NCT00840008 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 3157

Last updated 2011-08-26

No results posted yet for this study

Summary

The purpose of this study is to assess whether adherence to NVUGIB guidelines is improved with implementation of a national, tailored multifaceted intervention. Outcomes include adherence rates to two key endoscopic and pharmacological therapy guidelines together (primary), or adherence to these individually as well as to other recommendations (secondary). Patient outcomes and economic data are also assessed (tertiary).

Conditions

  • Peptic Ulcer Hemorrhage

Interventions

OTHER

Educational intervention

As per detailed protocol.

Sponsors & Collaborators

  • Horizon Health Network

    collaborator OTHER
  • Queen Elizabeth II Health Sciences Centre

    collaborator OTHER
  • St-Johns Health Sciences Centre

    collaborator UNKNOWN
  • Centre hospitalier de l'Université de Montréal (CHUM)

    collaborator OTHER
  • Jewish General Hospital

    collaborator OTHER
  • Montreal General Hospital

    collaborator OTHER
  • Royal Victoria Hospital, Canada

    collaborator OTHER
  • Maisonneuve-Rosemont Hospital

    collaborator OTHER
  • St Mary's Hospital, London

    collaborator OTHER
  • Centre Hospitalier Pierre Boucher

    collaborator UNKNOWN
  • Cité de la Santé Hospital

    collaborator UNKNOWN
  • Centre Hospitalier Anna Laberge

    collaborator UNKNOWN
  • Hotel Dieu Hospital

    collaborator OTHER
  • CHAUQ - Hopital Saint Sacrement and Hopital Enfant Jesus

    collaborator UNKNOWN
  • CISSS de Chaudière-Appalaches

    collaborator OTHER_GOV
  • Hamilton Health Sciences Corporation

    collaborator OTHER
  • Unity Health Toronto

    collaborator OTHER
  • Sunnybrook Health Sciences Centre

    collaborator OTHER
  • Toronto General Hospital

    collaborator OTHER
  • York Central Hospital, Ontario

    collaborator OTHER
  • Lakeridge Health Corporation

    collaborator OTHER
  • Guelph General Hospital

    collaborator UNKNOWN
  • London Health Sciences Centre

    collaborator OTHER
  • The Ottawa Hospital

    collaborator OTHER
  • Kingston Health Sciences Centre

    collaborator OTHER
  • Scarborough General Hospital

    collaborator OTHER
  • Matsqui-Sumas-Abbotsford General Hospital and Mission Memorial Hospital

    collaborator UNKNOWN
  • Vancouver General Hospital

    collaborator OTHER
  • Peter Lougheed Centre

    collaborator OTHER
  • Foothills Medical Centre

    collaborator OTHER
  • Alberta Health services

    collaborator OTHER
  • Grey Nuns Hospital

    collaborator UNKNOWN
  • University of Alberta

    collaborator OTHER
  • Royal Alexandra Hospital

    collaborator OTHER
  • Misericordia

    collaborator UNKNOWN
  • Royal University Hospital Foundation

    collaborator OTHER
  • Regina General Hospital

    collaborator OTHER
  • University of Manitoba

    collaborator OTHER
  • McGill University Health Centre/Research Institute of the McGill University Health Centre

    lead OTHER

Principal Investigators

  • Alan Barkun, MD · McGill University Health Centre/Research Institute of the McGill University Health Centre

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2009-12-31
Completion
2010-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00840008 on ClinicalTrials.gov